Spegra Tablets contain Dolutegravir, an integrase strand transfer inhibitor (INSTI) used in combination with other antiretroviral medicines for the treatment of HIV-1 infection. It works by blocking the HIV integrase enzyme, preventing the virus from inserting its genetic material into human cells and helping control viral multiplication.

Benefits

• Helps manage HIV-1 infection as part of combination therapy
• Reduces HIV viral replication
• Supports maintenance of immune system function
• Helps achieve and maintain viral suppression
• Convenient oral antiretroviral formulation

Active Ingredient

Dolutegravir

Pack Size

30 Tablets

Indications

Spegra is indicated for the treatment of HIV-1 infection in adults and eligible patients as part of combination antiretroviral therapy. It should be used only under the supervision of a qualified healthcare professional.

Directions for Use

Take Spegra exactly as prescribed by your healthcare provider. Swallow the tablet whole with water, with or without food, and take it consistently at the same time each day. Continue treatment as directed and do not stop therapy without medical advice.